a href=”http://www.isnr.org”>The International Society for Neurofeedback (ISNR) recently released 3 free (for members) nifty brochures designed to promote public awareness of neurofeedeback. The brochures target professionals and patients alike. Two of the 3 full color brochures highlight the benefits of ISNR membership for professionals, while the third encourages patients to explore neurofeedback as a possible treatment. All brochures discuss the effectiveness of neurofeedback with variety of psychological and developmental disorders. These brochures will also be available for a small fee to non-members. Check the end of this review for full size samples of each brochure.
The ISNR (International Society for Neurofeedback and Research) Research Foundation seeks to fund large scale, high quality quantitative electroencephalography (QEEG) and neurofeedback studies. They encourage researchers to immediately submit grant proposals for ADHD, Epilepsy, Autistic, and mild to moderate traumatic brain injury (TBI) populations. The ISNR Research Foundation further released a one page document with [...]
There has been increasing interest of late in very slow electroencephalographic (EEG) activity. While this sort of activity has been recorded and studied for many years, and used in biofeedback protocols in several applications, it is only recently gaining popularity as another tool with potential mainstream application to clinical neurofeedback. Whatever the tool, before embarking on a new clinical path, a general understanding of the existing research, as well as the technical and neuro-physiological basics is crucial to a successful experience. While there is no need to get overly carried away by the technical issues, a little knowledge can help avoid misunderstandings and common pitfalls, while hopefully leading to better clinical outcomes.
Using QEEG technology, researchers have identified a left frontotemporal dysfunction in persons who suffer from Obsessive-Compulsive Disorder, better known as OCD*. Persons with OCD have disturbing recurrent thoughts, as well as compulsive behaviors that are difficult to suppress and provide temporary relief from anxiety. The authors note that previous research has generally suggested a frontal [...]
Researchers compared the quantitative EEGs (QEEG) of 26 children with a history of stuttering to 21 age matched controls with no stuttering and may have identified important “EEG markers” of pediatric stuttering*. The authors’ epidemiological review of pediatric stuttering finds that this disorder afflicts approximately 1% of prepubertal children typically between 2 to 7 years of age with an peak onset around 3 to 4 years old with boys being 3 times more susceptible to this disorder.
I obtained a copy of a recent Position Statement from Blue Cross/Blue Shield that pertains to biofeedback and neurofeedback from a professional online neurofeedback user group. Unfortunately, Blue Cross/Blue Shield still considers neurofeedback “Investigational and Not Medically Necessary” for all conditions. It appears that Blue Cross/Blue Shield failed to include vital studies, some reviewed on this website, such as Gevensleben et al.’s (2009) ADHD research, Kouijzer et al.’s (2009) Autism research, and Hoedlmoser et al.’s (2008) sleep and memory research. A copy of the entire Position Statement is posted in this report.
In the latest neurofeedback news, Len Ochs, Ph.D. announced on April 24th in a private professional user group that the The Low Energy Neurofeedback System (LENS) is now a Food and Drug Administration (FDA) certified medical device. Dr. Ochs is the inventor of and a professional trainer of LENS.
The National Institute on Drug Abuse (NIDA) released their “5 Year Strategic Plan for 2009,” which calls for additional research for “The Exciting Potential of Neurofeedback” (pg. 33). A large national organization’s public recognition of the potential benefits of neurofeedback for substance abuse represents an important development for the field of neurofeedback and is a [...]